The removal of Zepbound and Mounjaro from the regulator’s shortage list could lead to restrictions on pharmacies making ...
England's National Health Services plans to offer Eli Lilly's weight-loss drugs to nearly a quarter million people as part of ...
Eli Lilly & Co.’s blockbuster weight-loss and diabetes drugs are no longer considered to be in shortage in the U.S., ...
The U.S. Food and Drug Administration removed Eli Lilly's blockbuster weight-loss and diabetes drugs from its shortage list ...
England's National Health Services will offer Eli Lilly's weight-loss drug to nearly a quarter million people as part of a ...
The two-year shortage of Eli Lilly’s blockbuster weight-loss and diabetes drugs is over, the U.S. Food and Drug ...
Eli Lilly said Wednesday it will invest $4.5 billion to build an advanced pharmaceutical drug manufacturing and development ...
U.S. drugmaker Eli Lilly said on Wednesday it will invest $4.5 billion to create a new center for advanced manufacturing and ...
Lilly will add the center to a site in Lebanon, Indiana, where it is already spending about $9 billion to improve ...
It's the largest Print with a Purpose collection ever from the Palm Beach brand, to benefit an organization with strong ties ...
The $4.5 billion investment will create the Lilly Medicine Foundry, a center that will combine research and manufacturing ...